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Nitric oxide and renal nerves: Comparison of effects on renal
circulation and sodium excretion in anesthetized rats.
Background. An array of vasoconstrictor and vasodilator
agents have the potential to control intrarenal circulation; how-
ever, their relative functional importance is unclear. We com-
pared here the importance of nitric oxide and renal nerves in
studies involving sequential blockade of nitric oxide synthesis
and renal denervation.
Methods. In anesthetized rats, N-nitro-L-arginine methyl
ester (L-NAME) was used for nonselective inhibition of nitric
oxide synthesis and 7-nitroindazole (7-NI) for inactivation of
neuronal isoform of nitric oxide synthase (nNOS). Acute uni-
lateral renal denervation was performed noninvasively enabling
observation of rapid changes. Renal cortical and medullary
blood flow was determined by laser Doppler flowmetry.
Results. L-NAME decreased medullary blood flow and cor-
tical blood flow, by 22% to 24%, whereas after 7-NI, medullary
blood flow decreased by 22% and cortical blood flow about
10% (all changes significant). In untreated rats denervation
significantly increased cortical blood flow (10% to 15%) but
not medullary blood flow. In rats treated with L-NAME dener-
vation partly prevented the post-inhibitor decrease in cortical
blood flow but not in medullary blood flow. After 7-NI treat-
ment, the decrease in cortical blood flow and medullary blood
flow did not occur or a partial restoration of flow was seen. The
denervation natriuresis was intact under L-NAME but attenu-
ated following 7-NI.
Conclusion. A reduction of medullary blood flow after 7-NI,
similar as after L-NAME, suggests that nitric oxide generated
by nNOS is mainly responsible for adequate perfusion of the
medulla whereas activity of nNOS and other isoform(s) is re-
quired to maintain cortical blood flow. Renal denervation partly
restored cortical blood flow reduced by nitric oxide blockade.
For medullary blood flow, such restoration was seen only after
inactivation of nNOS alone, suggesting an intrinsic interaction
of this isoform and renal nerves.
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Blood flow through the renal cortex and medulla that
would be optimal for renal function, and hence the main-
tenance of body fluid homeostasis, is determined by an
array of active agents, both vasoconstrictors and vasodila-
tors. Angiotensin II, vasopressin, norepinephrine (re-
leased at sympathetic nerve endings), and 20-HETE are
most often listed in the former group, as opposed to va-
sodilator nitric oxide, prostaglandins, and kinins. Under
certain conditions adenosine and endothelins are also in-
volved [1–2]. The potential role of all these agents has
been elucidated, however, their relative contribution to
the overall balance of intrarenal vascular resistance is not
known and the importance of some of them may be mi-
nor or negligible. This study explored the relative power
of nitric oxide system and renal sympathetic nerve ac-
tivity (RSNA) in vivo by examining the extent to which
elimination of nitric oxide, a potent dilator of intrarenal
vasculature, could be compensated for by the subsequent
elimination of the vasoconstrictor influence of RSNA.
However, systems controlling the intrarenal circula-
tion are probably redundant and, with time, the removal
of one component is likely to be replaced by others.
Therefore, the effects of interruption of RSNA should
be examined within a short time period. The standard
methodology of acute surgical/chemical renal denerva-
tion is invasive and at least 1 hour recovery must be
allowed after the maneuver; however, we recently de-
veloped a relatively noninvasive method enabling obser-
vations without such delay [3].
There is evidence that modulation of intrarenal circula-
tion and, particularly, of renal tubular sodium transport
by nitric oxide and RSNA involves a complex intrinsic
interaction between the two systems; this seems to be
the case with nitric oxide generated by the neuronal iso-
form of nitric oxide synthase (nNOS) [4, 5]. We suspected,
therefore, that the effects of inactivation of this isoform
were most likely to be specifically modulated by subse-
quent renal denervation and examined the impact thereof
both under relatively selective inhibition of nNOS
and after nonselective inhibition of the three isoforms
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expressed in the kidney [nNOS, inducible NOS (iNOS),
and endothelial NOS (eNOS)].
It is well established that renal vascular effects of hor-
monal and paracrine active agents, and effects of RSNA,
vary between the renal cortex and medulla [6]. Therefore,
in the present experiments perfusion in both zones was
measured separately by laser Doppler technique. To gain
further insight into the interaction between nitric oxide
and RSNA in control of intrarenal circulation, glomeru-
lar filtration rate (GFR) and sodium excretion were also
measured, to enable a rough estimation of changes in the
tubular transport.
METHODS
The experimental procedures were approved by the
Ethical Committee of the Medical Research Center,
Polish Academy of Sciences, Warsaw. Male Wistar rats
weighing 280 to 300 g were fed a standard pellet diet
(SSNIFF GmbH, Soest, Germany) and had free access
to water. They were anesthetized with sodium thiopen-
tal (Biochemie GmbH, Vienna, Austria) (100 mg/kg in-
traperitoneally). A polyethylene catheter was introduced
into the upper aorta via the carotid artery, for systemic
arterial blood pressure measurements. Renal perfusion
pressure was controlled using a suprarenal aortic snare
and measured via a femoral artery catheter. In order to
compensate for fluid losses, during surgical preparation
3% bovine albumin in Ringer solution was infused at
2.4 mL/hour. The left kidney was exposed via a flank
incision and placed in a plastic holder; the ureter was
cannulated for timed urine collections.
The tissue containing most of nerve fibers entering
the renal hilus was surrounded with a wire loop. To ob-
tain acute renal denervation, later during the experiment
this tissue was electrocoagulated by application of high
frequency current. This relatively noninvasive method,
recently developed in our laboratory [3], enabled con-
tinuation of all measurements directly after denervation.
For sham denervation, fat and connecting tissue in the
area caudal to the kidney was electrocoagulated.
The blood perfusion of the renal cortex and in-
ner medulla was measured and recorded separately us-
ing laser Doppler Periflux 4001 system (Perimed AB,
Jarfalla, Sweden). A needle probe (PF 402) was inserted
into the kidney to the depth of 5 mm and a PF 407 probe
was placed on kidney surface to measure medullary blood
flow and cortical blood flow, respectively. The technical
details of the technique were described recently [3].
Experimental protocols
At the end of surgical preparations and after place-
ment of laser Doppler probes, the infusion of albumin
was replaced by one which delivered 6 lCi of (methoxy-
3H) inulin in 1.2 mL of isotonic saline solution per hour,
preceded by a priming dose of 5 lCi, for measurements
of the GFR. Simultaneously, intravenous infusion of iso-
tonic saline at 2.4 mL/hour was started.
N-nitro-L-arginine methyl ester (L-NAME) studies in-
cluded three groups of rats. In two groups, after a 1-
hour control period, the saline infusion was replaced by
L-NAME, 10 lg/kg/min, and two further 30-minute mea-
suring periods were obtained. Thereafter, in one of these
two groups, the left kidney was denervated and in the
other one sham denervation was performed, in each case
there followed two 30-minute periods of L-NAME infu-
sion and two further periods after its cessation. In the
third group, the denervation was carried out during the
infusion of saline solvent of L-NAME.
The 7-nitroindazole (7-NI) studies included four
groups of rats. In three groups, after 1-hour control pe-
riod, 7-NI (Sigma Chemical Co., St. Louis, MO, USA),
a relatively selective inhibitor of nNOS, dissolved in lin-
seed oil, was injected intraperitoneally. After a 30-minute
observation period under 7-NI (two groups, under 7-NI
dose of 12.5 or 25 mg/kg), the kidney was denervated.
In the third group 25 mg/kg was given and sham den-
ervation was performed. In the fourth group linseed oil
solvent was given instead of 7-NI and denervation was
performed.
The analytical techniques for sodium and tritiated in-
ulin have been described previously [3]. GFR was cal-
culated as inulin clearance, and sodium excretion was
expressed in a standard way (UNaV, lmol/min) or fac-
tored by GFR (UNaV/GFR, lmol/mL × 100). The latter
index was used to replace fractional sodium excretion
(FENa), to avoid additional blood sampling for measure-
ment of plasma sodium concentration.
The standard error of mean (SEM) was used as a mea-
sure of data dispersion. The significance of changes was
first examined by repeat measurement analysis of vari-
ance (ANOVA), followed by Student t test for depen-
dent variables. For comparisons between groups, Student
t test for independent variables was used. P < 0.05 was
accepted as significant.
RESULTS
In all experiments, renal perfusion pressure (equiv-
alent with lower aortic pressure) was maintained at a
constant level. After L-NAME administration, systemic
arterial pressure (blood pressure) measured in the upper
aorta increased significantly from 119 ± 3.7 mm Hg to
137 ± 5.3 mm Hg (N = 16) and then remained almost
stable throughout experiments.
In the 7-NI studies the low dose (12.5 mg/kg intraperi-
toneally) did not significantly affect blood pressure,
whereas with 25 mg/kg an increase was seen (Table 1).
The highest blood pressure level was observed at 30 to
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Table 1. Comparison of effects of two doses of 7-nitroindazole(7-NI) on aortic blood pressure, cortical blood flow, and medullary blood flow
Control 12.5 mg/kg % Control 25 mg/kg %
Blood pressure mm Hg 115 ± 2 120 ± 3 +5.3 114 ± 4 134 ± 4a +11.8b
Cortical blood flow pu 548 ± 22 508 ± 25a −7.3 511 ± 27 465 ± 26a −9.1
Medullary blood flow pu 167 ± 18 152 ± 18a −9.0 140 ± 11 111 ± 9a −21.0b
Mean values ± SEM, pu is perfusion units (N = 12 in 12.5 mg group and N = 16 in 25 mg group). Blood pressure values represent suprarenal aortic pressure; renal
perfusion pressure was maintained constant; all the data were recorded 30 minutes after 7-NI administration.
aSignificantly different from the control; bSignificantly different for the corresponding value for the low dose.
Table 2. Renal hemodynamics and excretion data for two main
experimental protocols: Control L-NAME denervation and control
7-NI denervation
Control L-NAME Denervation
Cortical blood flow pu 439 ± 27 352 ± 27a 342 ± 29
Medullary blood flow pu 172 ± 14 128 ± 12a 125 ± 9
mL/min−1 0.79 ± 0.15 0.53 ± 0.09a 0.52 ± 0.13
UNaV lmol/min−1 0.19 ± 0.08 0.06 ± 0.01a 0.45 ± 0.16b
UNaV/GFR lmol/ 24 ± 5 15 ± 4 108 ± 41b
mL−1/100
V lL/min−1 3.9 ± 0.7 2.4 ± 0.5a 7.1 ± 1.8b
Control 7NI Denervation
Cortical blood flow pu 500 ± 41 461 ± 39a 478 ± 39
Medullary blood flow pu 139 ± 17 113 ± 13a 122 ± 17
GFR mL/min−1 1.20 ± 0.23 0.85 ± 0.14a 0.94 ± 0.12
UNa V lmol/min−1 0.34 ± 0.12 0.30 ± 0.10 0.52 ± 0.16b
UNaV/GFR lmol/ 39 ± 14 50 ± 16 70 ± 17b
mL−1/100
V lL/min−1 3.8 ± 0.9 3.2 ± 0.7a 5.8 ± 1.2b
Abbreviations are: GFR, glomerular filtration rate; UNaV, sodium excretion;
UNaV/GFR, sodium excretion factored by GFR, V, urine flow. Mean values
± SEM (N = 8). Post-inhibitor values are those measured 1 hour after the
start of intravenous infusion of L-NAME (10 lg/kg/min) or 30 minutes after
intraperitoneal injection of 7-NI (25 mg/kg). Denervation values are those
measured 2 hours after denervation.
aSignificantly different from the control at P < 0.05 or less; bSignificantly
different from post-inhibitor value at P < or less.
60 minutes after administration of 7-NI; thereafter it fell
progressively but at 90 minutes was still significantly ele-
vated. Cortical blood flow fell significantly and to a simi-
lar degree after both 7-NI doses, whereas the decrease in
medullary blood flow was significantly greater and longer
lasting after the high dose. Therefore, the data obtained
with the high dose were subsequently used for compari-
son with L-NAME effects and for evaluation of the im-
pact of subsequent renal denervation.
The data of Table 2 and Figure 1 show that L-NAME
decreased medullary blood flow and cortical blood flow
similarly, by 22% to 24%. After 7-NI, medullary blood
flow decreased to the same extent as after L-NAME,
whereas cortical blood flow decreased by about 10%.
GFR decreased after both inhibitors. L-NAME and 7-NI
decreased UNaV and V, except that no change in UNaV
was seen after 7-NI, despite a significant decrease in GFR.








Fig. 1. A comparison of N-nitro-L-arginine methyl ester (L-NAME)
and 7-nitroindazole (7-NI) effects on medullary blood flow (MBF) or
cortical blood flow (CBF). Mean% changes ± SEM are shown (N = 16).
∗Significantly different from medullary blood flow change after 7-NI;
†Significantly different from cortical blood flow change after L-NAME.
For assessment of the effects of renal denervation, the
data of Table 2 must be analyzed together with those of
Figure 2 (cortical blood flow and medullary blood flow)
and Figure 3 (GFR and UNaV); the figures include also
inhibitor solvent and sham denervation control groups,
and show the time course of post-denervation changes.
Table 2 shows that after denervation no significant
changes in cortical blood flow, medullary blood flow, or
GFR were noted whereas UNaV and V increased signif-
icantly. UNaV/GFR increased 7.2-fold and 1.4-fold (lat-
ter not significant) in rats pretreated with L-NAME and
7-NI, respectively.
Figure 2 shows that in untreated rats renal denervation
significantly increased cortical blood flow, and to a similar
degree in the control groups for L-NAME and for 7-NI
studies, whereas medullary blood flow did not change in
the former but decreased modestly in the latter group.
In rats treated with L-NAME, after denervation corti-
cal blood flow remained stable, whereas it decreased fur-
ther when sham denervation was performed; the profiles
differed significantly between the two groups. By con-
trast, renal denervation caused no amelioration of the
reduction in medullary blood flow compared to that in the
sham-denervated group. The two profiles were quite sim-
ilar. In rats pretreated with 7-NI, significant blunting of




































Fig. 2. Effects of inhibitors of nitric oxide
synthesis [N-nitro-L-arginine methyl ester (L-
NAME) or 7-nitroindazole (7-NI)] and subse-
quent renal denervation (den) or sham den-
ervation on cortical blood flow (CBF) and
medullary blood flow (MBF). Mean%± SEM
values are shown (N = 8). Symbols are () in-
hibitor followed by denervation; () inhibitor
followed by sham denervation; () inhibitor
solvent followed by denervation. Decreases in
cortical blood flow and medullary blood flow
after inhibitors were all significant. ∗From
this time point on, the values were signif-
icantly different from pre-denervation con-
trol; †Significant difference between upper





































40 Den or sham
Fig. 3. Effects of inhibitors of nitric oxide
synthesis [N-nitro-L-arginine methyl ester (L-
NAME) or 7-nitroindazole (7-NI)] and subse-
quent renal denervation (den) or sham den-
ervation on glomerular filtration rate (GFR)
and sodium excretion rate (UNaV). Mean% ±
SEM values are shown (N = 8). Symbols are:
() inhibitor followed by denervation; () in-
hibitor followed by sham denervation; () in-
hibitor solvent followed by denervation. After
inhibitors the changes in GFR were variable
and not significantly different from those after
inhibitor solvent; UNaV fall after L-NAME
was significant, other changes were modest.
∗From this time point on, the values were
significantly different from pre-denervation
value; †Significant difference between upper
and lower curve (denervation vs. sham). ‡The
first post-denervation value in 7-NI + dener-
vation group () significantly different from
its pre-denervation control.
both the cortical blood flow and medullary blood flow re-
sponses (compared to the sham-denervated group) were
observed.
The effects of renal denervation on GFR and sodium
excretion are shown in Table 2 and in Figure 3. The
changes in GFR were not significant, with one exception.
In the 7-NI pretreated rats, GFR showed a transient sig-
nificant increase and thereafter remained elevated above
predenervation control. This was in contrast to the stabil-
ity of GFR in the sham-denervated rats. UNaV increased
progressively, both in untreated and in inhibitor treated
rats (denervation natriuresis). L-NAME treatment did
not modify the denervation natriuresis with the end re-
sult that the profiles for untreated and inhibitor treated
rats were superimposable (Fig. 3). In the presence of
7-NI, the slope of the denervation natriuresis was visibly
less steep than in untreated rats; however, the difference
between the two profiles was not significant, due to a high
variability of values in the untreated group.
DISCUSSION
We found that nonselective inhibition of nitric oxide
synthesis with L-NAME increased blood pressure and
depressed intrarenal circulation, as documented in the
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early literature of the subject, at least in case of high doses
of this inhibitor [7].
It has been suggested that high doses of 7-NI, a rela-
tively selective inhibitor of nNOS, can also suppress nitric
oxide release by eNOS in vivo [8]. To minimize this risk
and still achieve a definite and prolonged inhibition of
nNOS, the effects of two doses of the drug, 12.5 and 25 mg/
kg, were first examined. The decrease in medullary blood
flow was greater in response to 25 mg/kg (Table 1) and
in subsequent studies this higher dose was used to in-
duce effective and long-lasting blockade. In a preliminary
study from this laboratory, 7-NI at 25 mg/kg was found to
decrease tissue nitric oxide concentration (measured by
nitric oxide selective electrodes) by 50% and 25% in rat
renal medulla and cortex, respectively [abstract; Grzelec-
Mojzesowicz M, Sadowski J, Nephrol Dial Transplant 18
(Suppl 4):574, 2003]. In many early reports the dose of
50 mg/kg was used for selective inhibition of nNOS, based
on dose-response studies in anesthetized rats [8–10].
Administration of 7-NI induced a significant and pro-
longed elevation of systemic blood pressure. It was found
in earlier studies that 7-NI or other, more selective nNOS
inhibitors increased [8, 9, 11], did not change [8, 12, 13]
or even decreased systemic blood pressure [14]. The ac-
tual response apparently depended on the route of in-
hibitor administration, rat strain, anesthetic utilized, and
the sodium content of the diet. It was unlikely that in our
experiments the increase in systemic blood pressure after
7-NI was due to elimination of nitric oxide derived from
intrarenal endothelia. First, the decrease in cortical blood
flow after 7-NI was much smaller than after L-NAME
(Fig. 2). Moreover, the action on cortical blood flow did
not increase with 7-NI in a dose-related way, whereas the
response in blood pressure did (Table 1), indicating that
the pressure increase did not depend on an increase in
intrarenal vascular resistance. The increase in systemic
blood pressure could have been due to some inhibition
of eNOS outside the kidney or, more likely, to elimina-
tion of neurally mediated vascular action of nitric oxide
derived from nNOS. Possible mechanisms of action could
involve presynaptic inhibition of norepinephrine release
at an intrarenal sympathetic neuro-effector junction or
on its postulated inhibitory action on the efferent outflow
from different levels of the sympathetic nervous system
[15, 16]. Measurements of post-ganglionic RSNA could
help clarify this uncertainty.
The inhibition of nNOS with 7-NI significantly de-
creased cortical blood flow and medullary blood flow.
The decrease in medullary blood flow was comparable
to that seen after L-NAME, which suggested that nitric
oxide generated by nNOS was critically important for
the maintenance of the medullary circulation (Fig. 1). By
contrast, the decrease in cortical blood flow was less than
a half of that seen after L-NAME, which suggested that
nitric oxide generated by all NOS isoforms was respon-
sible for the maintenance of adequate circulation within
the cortex.
nNOS can be detected in different medullary struc-
tures and in juxtamedullary glomeruli, whose efferent
arterioles supply the medullary vasa recta system. This
localization would be compatible with our functional
evidence for a major role of nitric oxide derived from
nNOS in the control of the medullary circulation. This
view is often expressed but the issue has been rarely ad-
dressed directly. There is also evidence against such a
role of this isoform: in a recent study Kakoki, Zou, and
Mattson [14] observed no change in medullary blood flow
or cortical blood flow after two highly selective nNOS in-
hibitors were given. Surprisingly, both these inhibitors
significantly reduced renal tissue nitric oxide concentra-
tion (determined by oxyhemoglobin trapping technique),
similarly in the cortex and medulla [14]. The reason for
the discrepancy between these results and ours is unclear;
moreover, a question arises on the causal relationship
between nitric oxide concentration in renal interstitium
and local blood flow. In our recent study, administration
of 7-NI or S-methyl-thiocitrulline, a more selective nNOS
inhibitor, reduced tissue nitric oxide in the medulla signif-
icantly more than in the cortex whereas modest decreases
in medullary blood flow and cortical blood flow were
of similar magnitude [abstract; Grzelec-Mojzesowicz M,
Sadowski J, Nephrol Dial Transplant 18 (Suppl 4):574,
2003].
The next question addressed here was whether den-
ervation would modify effects of previous inhibition of
nitric oxide synthesis. If so, we wanted to find out if the
influence of denervation on intrarenal circulation would
be similar in a kidney in which the activity of all the NOS
isoforms was reduced, compared to selective elimination
of nNOS. We found, indeed, that the effects of denerva-
tion did depend on the spectrum of NOS isoform inhi-
bition and, in addition, they were different in the cortex
compared to the medulla.
With intact nitric oxide synthesis, denervation in-
creased cortical blood flow, similar to our earlier report
[3]. After inhibition of nitric oxide synthesis, nonselective
or selective, denervation attenuated the usual decrease in
cortical blood flow, contrasting with a progressive deteri-
oration of the flow in the sham-denervation experiments
(Fig. 2). This attenuation was not surprising as the mecha-
nism involved could be more complex than a simple shift
of the balance of vasodilator and vasoconstrictor effects
toward dilatation. Nitric oxide, most probably the frac-
tion derived from nNOS, can limit the effects of sympa-
thetic input to the kidney by suppressing norepinehrine
release at the neuro-effector junction or/and by inhibit-
ing sympathetic outflow at different sites of the central
nervous system [11, 17, 18]. Possibly, a suppression of ni-
tric oxide synthesis eliminated these inhibitory effects,
leading to enhanced norepinephrine release at intrarenal
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sympathetic nerve endings to cause a vasoconstriction,
which manifested itself as a decrease in cortical blood
flow; the subsequent denervation would largely offset the
vasoconstriction to restore the flow.
There is increasing evidence that blood circulation in
the medulla is less sensitive to RSNA than that in the
cortex [6]. In agreement with our previous data [3], in
rats with intact nitric oxide synthesis renal denervation
did not increase medullary blood flow (Fig. 1). It was
therefore surprising that after elimination of nitric oxide
derived from nNOS, a post-denervation improvement of
medullary perfusion was seen, contrasting with a progres-
sive depression in the kidneys with intact renal nerves
(sham-denervation group) and in L-NAME treated rats.
Considering the evidence indicating inhibition of RSNA
by nitric oxide derived from nNOS [20], it is possible to
suggest that the sympathetic neural input to the medulla
of the innervated kidney could have been largely sup-
pressed; therefore, the denervation was without effect.
When the neuroinhibitory effect of nitric oxide had been
abolished by 7-NI, the medullary vasculature became
exposed to constrictor action of renal nerves and after
subsequent denervation an improvement of medullary
perfusion was seen. This observation strengthens the ev-
idence for important functional role of inhibitory modu-
lation of RSNA by nitric oxide in the renal medulla. Such
modulation may not be equally important in the cortex
where denervation increased blood flow even with an in-
tact nitric oxide synthesis. In the medulla, the active frac-
tion of nitric oxide could be generated by nNOS located in
the vicinity of adrenergic neuro-effector junctions, possi-
bly at nitrergic nerve endings [17, 20]. Alternatively, nitric
oxide generated by nNOS located in the efferent arteri-
oles of juxtamedullary glomeruli or that diffusing from
nNOS in the macula densa or inner medullary collecting
duct cells could be involved [21].
It is not clear why denervation failed to ameliorate the
decrease in the medullary circulation in rats in which all
the NOS isoforms were at least partly inhibited by L-
NAME. A nonselective inhibition of nitric oxide synthe-
sis has been reported to increase RSNA [19] and enhance
renal norepinephrine release (overflow) augmented by
renal nerve stimulation [22, 23]. This indicates that un-
der L-NAME, RSNA was high, and still denervation was
without effect in the medulla, in contrast to the cortex.
Possibly, the degree of nNOS inhibition achieved with
L-NAME was insufficient and lower than that achieved
with 7-NI. However, we found in our preliminary stud-
ies that the decrease in nitric oxide concentration in the
medullary tissue was quite similar after the doses of L-
NAME and of 7-NI used in the present study [abstract;
Grzelec-Mojzesowicz M, Sadowski J, Nephrol Dial Trans-
plant 18 (Suppl 4):574, 2003]. Admittedly, extracellular
nitric oxide may not be a good index of nitric oxide activ-
ity at effector sites, as suggested by a lack of correlation
between tissue nitric oxide and local blood perfusion. (see
the abstract quoted above and [14]). Nevertheless, it re-
mains unclear why elimination of the activity of nNOS,
but only with the activity of the other NOS isoforms left
intact, uncovers the vasodilator effect of denervation in
the renal medulla.
The presence of nNOS in the glomerular arterioles and
in the macula densa [24–26] suggests that nitric oxide gen-
erated by this isoform may be specifically involved in the
control of tubuloglomerular feedback, GFR and renin
secretion [10, 27]. Unfortunately, a major variability of
GFR during the present experiments makes it difficult to
dissect meaningful changes in response to NOS blockade
or subsequent denervation. In general, GFR tended to
decrease after either NOS inhibitor and to increase after
denervation.
An ultimate effect of inhibition of nitric oxide synthe-
sis on sodium excretion would be the resultant of three
individual influences. First, elimination of a direct modu-
latory action of nitric oxide on the tubular sodium trans-
port should be considered. A majority of studies indicates
that in the proximal tubule this action is inhibitory [4, 5,
28]; however, stimulation was also reported [29, 30]. The
actual effect probably depended on the local nitric oxide
concentration and the action on different tubular sodium
transport mechanisms [4, 28]. In the case of transport in
the thick ascending limb of Henle’s loop, the action is
inhibitory and nitric oxide derived from eNOS is respon-
sible [31–33].
Second, a post-inhibitor increase in arterial pressure
would limit the tubular transport and lead to pressure
natriuresis. This factor was excluded in the present ex-
periments, as the renal perfusion pressure was mainained
constant. The third effect would be antinatriuresis sec-
ondary to depression of blood flow and GFR.
The modest decrease in sodium excretion observed af-
ter L-NAME was likely the conglomerate effect of some
direct modulation of the tubular transport and a decrease
in renal hemodynamics, but the relative contribution of
either factor cannot be defined. Interestingly, after 7-NI
the value of UNaV/GFR increased significantly, in associ-
ation with a substantial decrease in GFR (Table 1). This
could indicate that under basal conditions the tubular
sodium transport was being stimulated rather than in-
hibited by nitric oxide derived from nNOS. After elimi-
nation of this effect using 7-NI, denervation resulted in
only a modest natriuresis, much smaller than that ob-
served in L-NAME pretreated rats. Possibly, in agree-
ment with the data of Wu, Harris, and Johns [28], the basal
tubular sodium transport was under tonic influence of ni-
tric oxide generated by nNOS and the effect was depen-
dent on renal nerve activity. However, in disagreement
with these data, an increase in UNaV/GFR (a decrease
in the transport) after 7-NI suggested that the effect on
the transport was stimulatory. Presumably, a decrease in
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nerve-dependent fraction of sodium transport after elimi-
nation of nitric oxide derived from nNOS left only limited
space for a further decrease in this fraction, hence only a
minor natriuresis was seen after subsequent denervation.
It seems paradoxic, however, that this chain of events
was observed in the absence of nitric oxide generated by
nNOS only when associated with intact activity of eNOS
and iNOS. Denervation natriuresis was of usual magni-
tude when all the synthase isoforms were inhibited. The
explanation should perhaps be sought in different roles
of nitric oxide generated by different NOS isoforms in
modifying renal nerve–dependent and independent frac-
tions of the tubular sodium transport. A slight increase
in the tubular transport (a decrease in UNaV/GFR) seen
after elimination of all the NOS isoforms, in contrast to a
decrease in the transport seen after elimination of nNOS
alone, suggests that under basal conditions the nitric ox-
ide derived from eNOS and possibly also from iNOS
inhibited the tubular transport, slightly prevailing over
stimulatory action of nitric oxide derived from nNOS. It
can be speculated that this inhibition was not nerve de-
pendent and, therefore, denervation triggered a further
decrease in the transport and a pronounced natriuresis
developed. Given the extreme complexity of renal nerve
and nitric oxide interaction on the tubular sodium trans-
port [4, 5], no further speculation would be warranted on
basis of the present whole kidney experiments.
CONCLUSION
A reduction of medullary blood flow after 7-NI similar
to that seen after L-NAME suggests that adequate per-
fusion of the medulla is largely dependent on nitric ox-
ide generated by nNOS; the activity of nNOS and other
isoform(s) is needed to maintain cortical blood flow. The
renal denervation efficiently opposed the decrease of cor-
tical blood flow which followed a nonselective NOS or
selective nNOS inhibition. It is unclear why only after in-
activation of nNOS alone (not in untreated rats or under
L-NAME) did denervation help restore medullary blood
flow. Further studies are also needed to elucidate the role
of individual NOS isoforms in control of tubular sodium
transport.
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